Skip to main content
On July 8, 2016, the federal Department of Health and Human Services released this final rule regarding treatment for opioid use disorders. This final rule increases access to medication-assisted treatment with buprenorphine and the combination buprenorphine/naloxone in the office-based setting as authorized under the United States Code. This final rule is effective on August 8, 2016 . . .
Content Restricted

This article is reserved for members with an active Standard Membership. Please purchase a Standard Membership to view this resource.

Purchase A Standard Account

Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!

Close

Support Request

Need help now?

Call our toll-free phone number 877-350-6463